论文部分内容阅读
目的甲胎蛋白(AFP)和α-L岩藻糖苷酶(AFU)联合检测对不同肝脏疾病的临床应用价值探讨。方法分别采用微粒子化学发光法和CNPF速率法对不同肝脏疾病和健康体检者的血清AFP和AFU进行测定。结果原发性肝癌患者AFP和AFU两者均明显增高,并均达阳性值;肝硬化患者两者均增高,但未达阳性值;慢性肝炎患者两者均增高,但不明显。急性肝炎患者AFU明显增高,而AFP少见增高。结论 AFP和AFU联合检测可提高肝脏相关疾病尤其是原发性肝癌的诊断,并且两者具有互补作用。
Objective To investigate the clinical value of combined detection of alpha fetoprotein (AFP) and alpha-L fucosidase (AFU) in different liver diseases. Methods The serum AFP and AFU of different liver diseases and healthy subjects were measured by the method of microparticle chemiluminescence and CNPF. Results Both AFP and AFU in patients with primary liver cancer were significantly higher than those in patients with primary liver cancer, both of which reached a positive value. Both of the patients with cirrhosis increased but did not reach the positive value. Both patients with chronic hepatitis had increased, but not obvious. AFU patients with acute hepatitis was significantly higher, while AFP rare increase. Conclusion Combined detection of AFP and AFU can improve the diagnosis of liver-related diseases, especially primary liver cancer, and they have complementary effects.